BackgroundCheck.run
Search For

Richard S Vivilecchia, 51Buzzards Bay, MA

Richard Vivilecchia Phones & Addresses

Buzzards Bay, MA   

53 Dean St, Everett, MA 02149    617-3870074    617-3876257    617-8723628   

North Easton, MA   

Rockaway, NJ   

Hull, MA   

Delray Beach, FL   

Mentions for Richard S Vivilecchia

Publications & IP owners

Us Patents

Stabilized Pharmaceutical Compositions Comprising Acid Donors

US Patent:
6509350, Jan 21, 2003
Filed:
Aug 17, 2001
Appl. No.:
09/931750
Inventors:
Richard V. Vivilecchia - Rockaway NJ
Bruce A. Ross - Fredon NJ
Assignee:
Novartis AG - Basel
International Classification:
A61K 3147
US Classification:
514307, 546146, 562575
Abstract:
The invention relates to the use of certain acid donors as stabilizers in pharmaceutical compositions, and to the stabilized pharmaceutical compositions resulting therefrom.

Stabilized Pharmaceutical Compositions Comprising Acid Donors

US Patent:
6790861, Sep 14, 2004
Filed:
May 23, 2003
Appl. No.:
10/445452
Inventors:
Richard V. Vivilecchia - Rockaway NJ
Bruce A. Ross - Fredon NJ
Assignee:
Novartis AG - Basel
International Classification:
A61K 3140
US Classification:
514423, 548566
Abstract:
The invention relates to the use of certain acid donors as stabilizers in pharmaceutical compositions, and to the stabilized pharmaceutical compositions resulting therefrom.

Stabilized Pharmaceutical Compositions Comprising Acid Donors

US Patent:
2003013, Jul 24, 2003
Filed:
Oct 29, 2002
Appl. No.:
10/282659
Inventors:
Richard Vivilecchia - Rockaway NJ, US
Bruce Rose - Newton NJ, US
International Classification:
A61K031/47
A61K009/20
US Classification:
514/307000, 424/465000
Abstract:
The invention relates to the use of certain acid donors as stabilizers in pharmaceutical compositions, and to the stabilized pharmaceutical compositions resulting therefrom.

Salts Of Nateglinide

US Patent:
2005023, Oct 20, 2005
Filed:
Mar 10, 2003
Appl. No.:
10/507255
Inventors:
Paul Sutton - Parsippany NJ, US
Richard Vivilecchia - Rockaway NJ, US
David Parker - West Milford NJ, US
Marilyn De La Cruz - Matawan NJ, US
International Classification:
A61K031/7008
A61K031/198
C07C233/81
A61K031/205
US Classification:
514563000, 562450000, 514062000, 536055300
Abstract:
The present invention relates to salts of organic acid, in particular salt of nateglinide, combined preparations comprising one or more salts of nateglinide and, optionally, one or more additional ingredients and the use thereof in pharmaceutical compositions for preventing or treating diabetes, cardiovascular diseases, or conditions associated therewith.

Salts Of Nateglinide

US Patent:
2009014, Jun 4, 2009
Filed:
Feb 6, 2009
Appl. No.:
12/366936
Inventors:
Paul Allen Sutton - Parsippany NJ, US
Richard V. Vivilecchia - Rockaway NJ, US
David John Parker - West Milford NJ, US
Marilyn De La Cruz - Matawan NJ, US
International Classification:
A61K 31/195
C07C 229/02
A61P 3/00
A61P 9/00
US Classification:
514563, 562450
Abstract:
The present invention relates to salts of organic acid, in particular salt of nateglinide, combined preparations comprising one or more salts of nateglinide and, optionally, one or more additional ingredients and the use thereof in pharmaceutical compositions for preventing or treating diabetes, cardiovascular disease, or conditions associated therewith.

Stabilized Pharmaceutical Compositions Comprising Acid Donors

US Patent:
6300361, Oct 9, 2001
Filed:
Jun 6, 1995
Appl. No.:
8/469529
Inventors:
Richard V. Vivilecchia - Rockaway NJ
Bruce A. Ross - Fredon NJ
Assignee:
Novartis AG - Basle
International Classification:
A61K 3140
US Classification:
514409
Abstract:
The invention relates to the use of certain acid donors as stabilizers in pharmaceutical compositions, and to the stabilized pharmaceutical compositions resulting there-from.

Stabilized Pharmaceutical Compositions Comprising An Hmg-Coa Reductase Inhibitor Compound

US Patent:
5356896, Oct 18, 1994
Filed:
Dec 22, 1992
Appl. No.:
7/995252
Inventors:
Mohan B. Kabadi - Marlboro NJ
Richard V. Vivilecchia - Rockaway NJ
Assignee:
Sandoz Ltd. - Basel
International Classification:
A61K 31505
A61K 31435
A61K 3144
A61K 31405
A61K 3119
US Classification:
514256
Abstract:
A pharmaceutical dosage form comprising an HMG-CoA reductase inhibitor compound, e. g. , fluvastatin sodium, is disclosed which is stabilized against pH-related degradation by an alkaline stabilizing medium capable of imparting a pH of at least 8 to an aqueous solution or dispersion of the composition.

Stabilized Pharmaceutical Compositions Comprising Acid Donors

US Patent:
6300362, Oct 9, 2001
Filed:
Jun 6, 1995
Appl. No.:
8/472412
Inventors:
Richard V. Vivilecchia - Rockaway NJ
Bruce A. Ross - Fredon NJ
Assignee:
Novartis AG (formerly Sandoz Ltd.) - Basel
International Classification:
A61K 3140
US Classification:
514409
Abstract:
The invention relates to the use of certain acid donors as stabilizers in pharmaceutical compositions, and to the stabilized pharmaceutical compositions resulting therefrom.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.